Transglutaminase participates in UVB-induced cell death pathways in human corneal epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 10, 2006, Pages 4295-4301

  Tong, Louis ^a,b,c   Chen, Zhuo ^a   De Paiva, Cintia S ^a   Beuerman, Roger ^c   Li, De Quan ^a   Pflugfelder, Stephen C ^a  

^a CULLEN EYE INSTITUTE   (United States)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^c SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CADAVERINE; CASPASE; CASPASE 3; DANSYLCADAVERINE; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DIGOXIGENIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; CASP3 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSGLUTAMINASE 2;

APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CORNEA EPITHELIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRAVIOLET B RADIATION; CELL LINE; CELL SURVIVAL; DRUG EFFECT; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET RADIATION;

APOPTOSIS; CASPASE 3; CASPASES; CELL LINE; CELL SURVIVAL; EPITHELIUM, CORNEAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GTP-BINDING PROTEINS; HUMANS; IN SITU NICK-END LABELING; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; TRANSGLUTAMINASES; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS;

EID: 33750584428     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0412     Document Type: Article

References (50)

1. Lu L, Wang L, Shell B. UV-induced signaling pathways associated with corneal epithelial cell apoptosis. Invest Ophthalmol Vis Sci. 2003;44:5102-5109.
2. Shimmura S, Tadano K, Tsubota K. UV dose-dependent caspase activation in a corneal epithelial cell line. Curr Eye Res. 2004;28:85-92.
3. Wickert H, Zaar K, Grauer A, John M, Zimmermann M, Gillardon F. Differential induction of proto-oncogene expression and cell death in ocular tissues following ultraviolet irradiation of the rat eye. Br J Ophthalmol. 1999;83:225-230.
4. Buschke W, Fridenwald JS, Moses SG. Effects of ultraviolet radiation on corneal epithelium: mitosis, nuclear fragmentation, post-traumatic cell movements, loss of tissue cohesion. J Cell Comp Physiol. 1945;26:147-164.
5. Raghunath M, Cankay R, Kubitscheck U, et al. Transglutaminase activity in the eye: cross-linking in epithelia and connective tissue structures. Invest Ophthalmol Vis Sci. 1999;40:2780-2787.
6. Zhang W, Shiraishi A, Suzuki A, Zheng X, Kodama T, Ohashi Y. Expression and distribution of tissue transglutaminase in normal and injured rat cornea. Curr Eye Res. 2004;28:37-45.
7. Kim YJ, Park ES, Song KY, Park SC, Kim JC. Glutathione transferase (class pi) and tissue transglutaminase (Tgase C) expression in pterygia. Korean J Ophthalmol. 1998;I2:6-13.
8. Sohn J, Kim TI, Yoon YH, Kim JY, Kim SY. Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. J Clin Invest. 2003;111:121-128.
9. Toshino A, Shiraishi A, Zhang W, Suzuki A, Kodama T, Ohashi Y. Expression of keratinocyte transglutaminase in cornea of vitamin a-deficient rats. Curr Eye Res. 2005;30:731-739.
10. Yeh S, Song XJ, Farley W, Li DQ, Stern ME, Pflugfelder SC. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci. 2003;44:124-129.
11. Nakamura T, Nishida K, Dota A, Matsuki M, Yamanishi K, Kinoshita S. Elevated expression of transglutaminase 1 and keratinization-related proteins in conjunctiva in severe ocular surface disease. Invest Ophthalmol Vis Sci. 2001;42:549-556.
12. Shin DM, Jeon JH, Kim CW, et al. Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis. J Biol Chem. 2004;279:15032-15039.
13. Melino G, Candi E, Steinert PM. Assays for transglutaminases in cell death. Methods Enzymol. 2000;322:433-472.
14. Piacentini M, Amendola A, Ciccosanti F, et al. Type 2 transglutaminase and cell death. Prog Exp Tumor Res. 2005;38:58-74.
15. Fesus L, Szondy Z. Transglutaminase 2 in the balance of cell death and survival. FEBS Lett. 2005;579:3297-3302.
16. Milakovic T, Tucholski J, McCoy E, Johnson GV. Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J Biol Chem. 2004;279:8715-8722.
17. Rosette C, Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science. 1996;274:1194-1197.
18. Niederkorn JY, Mayhew E, Mellon J, Hegde S. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival. Invest Ophthalmol Vis Sci. 2004;45:2674-2681.
19. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003;114:181-190.
20. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
21. Kim HS, Jun Song X, de Paiva CS, Chen Z, Pflugfelder SC, Li DQ. Phenotypic characterization of human corneal epithelial cells expanded ex vivo from limbal explant and single cell cultures. Exp Eye Res. 2004;79:41-49.
22. Tong L, Corrales RM, Villareal A, Chen Z, Li DQ, Beuerman RW, Pflugfelder SC. Expression and regulation of cornified envelope proteins in human corneal epithelium. Invest Ophthalmol Vis Sci. 2006;47:1938-1946.
23. Igarashi S, Koide R, Shimohata T, et al. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet. 1998;18:111-117.
24. Corrales RM, Calonge M, Herreras JM, Saez V, Mayo A, Chaves FJ. Levels of mucin gene expression in normal human conjunctival epithelium in vivo. Curr Eye Res. 2003;27:323-328.
25. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004;45:4293-4301.
26. Strong B, Farley W, Stern ME, Pflugfelder SC. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea. 2005;24:80-85.
27. Chen Z, de Paiva CS, Luo L, Kretzer FL, Pflugfelder SC, Li DQ. Characterization of putative stem cell phenotype in human limbal epithelia. Stem Cells. 2004;22:355-366.
28. Kueng W, Silber E, Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem. 1989;182:16-19.
29. Li DQ, Tseng SC. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol. 1995;163:61-79.
30. Parameswaran KN, Velasco PT, Wilson J, Lorand L. Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase. Proc Natl Acad Sci USA. 1990;87:8472-8475.
31. Taki M, Shiota M, Taira K. Transglutaminase-mediated N- and C-terminal fluorescein labeling of a protein can support the native activity of the modified protein. Protein Eng Des Sel. 2004;17:119-126.
32. Morris MC, Depollier J, Mery J, Heitz F, Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol. 2001;19:1173-1176.
33. Evans RM, Fink LM. Identification of transmembrane bridging proteins in the plasma membrane of cultured mouse L cells. Proc Natl Acad Sci USA. 1977;74:5341-5344.
34. Katoh S, Midorikami J, Takasu S, Ohkubo Y. Involvement of membrane-bound transglutaminase in the invagination of transferrin into rat reticulocyte plasma membrane. Biol Pharm Bull. 1994;17:1003-1007.
35. Chuang DM. Beta-adrenergic receptor internalization and processing: role of transglutaminase and lysosomes. Mol Cell Biochem. 1984;58:79-89.
36. Pan BT, Johnstone R. Selective externalization of the transferrin receptor by sheep reticulocytes in vitro: response to ligands and inhibitors of endocytosis. J Biol Chem. 1984;259:9776-9782.
37. Julian C, Speck NA, Pierce SK. Primary amines inhibit the triggering of B lymphocytes to antibody synthesis. J Immunol. 1983;130:91-96.
38. Davies PJ, Cornwell MM, Johnson JD, Reggianni A, Myers M, Murtaugh MP. Studies on the effects of dansylcadaverine and related compounds on receptor-mediated endocytosis in cultured cells. Diabetes Care. 1984;7(suppl)1:35-41.
39. Davies PJ, Murtaugh MP. Transglutaminase and receptor-mediated endocytosis in macrophages and cultured fibroblasts. Mol Cell Biochem. 1984;58:69-77.
40. Kulms D, Schwarz T. Independent contribution of three different pathways to ultraviolet-B-induced apoptosis. Biochem Pharmacol. 2002;64:837-841.
41. Kuncio GS, Tsyganskaya M, Zhu J, et al. TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells. Am J Physiol. 1998;274:G240-G245.
42. Koliopoulos JX, Margaritis LH. Response of the cornea to far ultraviolet light: an ultrastructural study. Ann Ophthalmol. 1979;11:765-769.
43. Alibardi L, Toni M. Immunolocalization and characterization of cornification proteins in snake epidermis. Anat Rec A Dtscov Mol Cell Evol Biol. 2005;282:138-146.
44. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell. 1996;87:171.
45. Fromigue O, Louis K, Dayem M, et al. Gene expression profiling of normal human pulmonary fibroblasts following coculture with non-small-cell lung cancer cells reveals alterations related to matrix degradation, angiogenesis, cell growth and survival. Oncogene. 2003;22:8487-8497.
46. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J. 1996;10:587-597.
47. Shubayev VI, Myers RR. Axonal transport of TNF-alpha in painful neuropathy: distribution of ligand tracer and TNF receptors. J Neuroimmunol. 2001;114:48-56.
48. Falasca L, Iadevaia V, Ciccosanti F, Melino G, Serafino A, Piacentini M. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment. J Immunol. 2005;174:7330-7340.
49. Kweon SM, Lee ZW, Yi SJ, et al. Protective role of tissue transglutaminase in the cell death induced by TNF-alpha in SH-SY5Y neuroblastoma cells. J Biochem Mol Biol. 2004;37:185-191.
50. Mishra S, Murphy LJ. Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J Biol Chem. 2004;279:23863-23868.